Identification of occult brain metastases amenable to stereotactic radiosurgery by motexafin gadolinium (MGd) based treatment planning MRI: Results of a phase II trial of MGd and whole brain radiotherapy (WBRT) with stereotactic radiosurgery (SRS) Article

Mehta, MP, Dagnault, A, Chabot, P et al. (2007). Identification of occult brain metastases amenable to stereotactic radiosurgery by motexafin gadolinium (MGd) based treatment planning MRI: Results of a phase II trial of MGd and whole brain radiotherapy (WBRT) with stereotactic radiosurgery (SRS) . JOURNAL OF CLINICAL ONCOLOGY, 25(18_suppl), 2037-2037. 10.1200/jco.2007.25.18_suppl.2037

cited authors

  • Mehta, MP; Dagnault, A; Chabot, P; Suh, J; Chang, E; Fortin, M; Timmerman, R; Grecula, J; Eubank, L; Renschler, MF

authors

publication date

  • June 20, 2007

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • Brain Cancer
  • Brain Disorders
  • Cancer
  • Clinical Research
  • Neurosciences
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • American Society of Clinical Oncology (ASCO)

start page

  • 2037

end page

  • 2037

volume

  • 25

issue

  • 18_suppl